Analysis of BRCA1/BRCA2 genes' contribution to breast cancer susceptibility in high risk Jewish Ashkenazi women

Familial Cancer

Volumn 8, Issue 2, 2009, Pages 127-133

  Distelman Menachem, Tal ^a   Shapira, Tal ^a   Laitman, Yael ^a   Kaufman, Bella ^a,b   Barak, Frida ^c   Tavtigian, Sean ^d   Friedman, Eitan ^a,b  

^a GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c BARZILAI MEDICAL CENTER   (Israel)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

BRCA1 BRCA2; Genetic susceptibility; Major gene rearrangements; Sequence variants of unknown significance

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; EXON; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE REARRANGEMENT; GENETIC ANALYSIS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; PRIORITY JOURNAL;

BRCA2 PROTEIN; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JEWS; MALE; NEOPLASM PROTEINS; OVARIAN NEOPLASMS;

EID: 67349199178     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-008-9216-6     Document Type: Article

References (44)

1. MC King JH Marks JB Mandell 2003 Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2 Science 302 5645 643 646 10.1126/science.1088759
2. A Antoniou PD Pharoah S Narod 2003 Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies Am J Hum Genet 72 1117 1130 10.1086/375033
3. JP Schouten CJ McElgunn R Waaijer 2002 Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification Nucleic Acids Res 30 12 e57
4. AM Moisan J Fortin M Dumont 2006 No evidence of BRCA1/2 genomic rearrangements in high-risk French-Canadian breast/ovarian cancer families Genet Test 10 2 104 115 10.1089/gte.2006.10.104
5. N Puget D Torchard OM Serova-Sinilnikova 1997 A 1-kb Alu-mediated germline deletion removing BRCA1 exon 17 Cancer Res 57 5 828 831
6. A Petrij-Bosch T Peelan M van Vliet 1997 BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients Nat Genet 17 3 341 345 10.1038/ng1197-341
7. P Vasickova E Machackova M Lukesova 2007 High occurrence of BRCA1 intragenic rearrangements in hereditary breast and ovarian cancer syndrome in the Czech Republic BMC Med Genet 11 8 32
8. S Gad A Aurias N Puget 2001 Color bar coding the BRCA1 gene on combed DNA: a useful strategy for detecting large gene rearrangements Genes Chromosomes Cancer 31 75 84 10.1002/gcc.1120
9. S Gad M Klinger V Caux-Moncoutier 2002 Bar code screening on combed DNA for large rearrangements of the BRCA1 and BRCA2 genes in French breast cancer families J Med Genet 39 817 821 10.1136/jmg.39.11.817
10. AM Woodward TA Davis AG Silva 2005 Large genomic rearrangements of both BRCA2 and BRCA1 are a feature of the inherited breast/ovarian cancer phenotype in selected families J Med Genet 42 e31 10.1136/jmg.2004.027961
11. S Gad V Caux-Moncoutier S Pagès-Berhouet 2002 Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer families Oncogene 3: 21 44 6841 6847
12. M Montagna M Dalla Palma C Menin 2003 Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families Hum Mol Genet 12 9 1055 1061 10.1093/hmg/ddg120
13. S Armaou I Konstantopoulou T Anagnostopoulos 2007 Novel genomic rearrangements in the BRCA1 gene detected in Greek breast/ovarian cancer patients Eur J Cancer 43 2 443 453 10.1016/j.ejca.2006.09.021
14. TM Smith MK Lee CI Szabo 1996 Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1 Genome Res 6 1029 1049 10.1101/gr.6.11.1029
15. N Puget S Gad L Perrin-Vidoz 2002 Distinct BRCA1 rearrangements involving the BRCA1 pseudogene suggest the existence of a recombination hot spot Am J Hum Genet 70 858 865 10.1086/339434
16. JE Garber K Offit 2005 Hereditary cancer predisposition syndromes J Clin Oncol 23 2 276 292 10.1200/JCO.2005.10.042
17. ND Kauff P Perez-Segura ME Robson 2002 Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer families J Med Genet 39 8 611 614 10.1136/jmg.39.8.611
18. J Swensen M Hoffman MH Skolnick 1997 Identification of a 14 kb deletion involving the promoter region of BRCA1 in a breast cancer family Hum Mol Genet 6 1513 1517 10.1093/hmg/6.9.1513
19. N Puget D Stoppa-Lyonet OM Sinilnikova 1999 Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions Cancer Res 59 455 461
20. SJ Ramus PA Harrington C Pye 2007 Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer Hum Mutat 28 12 1207 1215 10.1002/humu.20599
21. YK Lim PTC Iau AB Ali 2007 Identification of novel BRCA large genomic rearrangements in Singapore Asian breast and ovarian patients with cancer Clin Genet 71 4 331 342 10.1111/j.1399-0004.2007.00773.x
22. S Gutiérrez-Enríquez M de la Hoya C Martínez-Bouzas 2007 Screening for large rearrangements of the BRCA2 gene in Spanish families with breast/ovarian cancer Breast Cancer Res Treat 103 1 103 107 10.1007/s10549-006-9376-8
23. S Agata M Dalla Palma M Callegaro 2005 Large genomic deletions inactivate the BRCA2 gene in breast cancer families J Med Genet 42 10 e64 10.1136/jmg.2005.032789
24. I Tournier BB Paillerets H Sobol 2004 Significant contribution of germline BRCA2 rearrangements in male breast cancer families Cancer Res 64 8143 8147 10.1158/0008-5472.CAN-04-2467
25. J Staaf T Törngren E Rambech 2008 Detection and precise mapping of germline rearrangements in BRCA1, BRCA2, MSH2, and MLH1 using zoom-in array comparative genomic hybridization (aCGH) Hum Mutat 29 4 555 564 10.1002/humu.20678
26. Miramar MD, Calvo MT, Rodriguez A et al (2008) Genetic analysis of BRCA1 and BRCA2 in breast/ovarian cancer families from Aragon (Spain): two novel truncating mutations and a large genomic deletion in BRCA1. Breast Cancer Res Treat [Epub ahead of print]
27. M Ratajska I Brozek E Senkus-Konefka 2008 BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland Oncol Rep 19 1 263 268
28. D Purnomosari G Pals A Wahyono 2007 BRCA1 and BRCA2 germline mutation analysis in the Indonesian population Breast Cancer Res Treat 106 2 297 304 10.1007/s10549-006-9493-4
29. ME Nowee AM Snijders DA Rockx 2007 DNA profiling of primary serous ovarian and fallopian tube carcinomas with array comparative genomic hybridization and multiplex ligation-dependent probe amplification J Pathol 213 1 46 55 10.1002/path.2217
30. M Konecny K Zavodna V Vranova 2008 Identification of rare complete BRCA1 gene deletion using a combination of SNP haplotype analysis, MLPA and array-CGH techniques Breast Cancer Res Treat 109 3 581 583 10.1007/s10549-007-9670-0
31. S Gutiérrez-Enríquez J Balmaña M Baiget 2008 Detection of the CHEK2 1100delC mutation by MLPA BRCA1/2 analysis: a worthwhile strategy for its clinical applicability in 1100delC low-frequency populations? Breast Cancer Res Treat 107 3 455 457 10.1007/s10549-007-9555-2
32. R Karhu E Laurila A Kallioniemi 2006 Large genomic BRCA2 rearrangements and male breast cancer Cancer Detect Prev 30 6 530 534 10.1016/j.cdp.2006.10.002
33. M Thomassen AM Gerdes D Cruger 2006 Low frequency of large genomic rearrangements of BRCA1 and BRCA2 in western Denmark Cancer Genet Cytogenet 168 2 168 171
34. M de la Hoya S Gutiérrez-Enríquez E Velasco 2006 Genomic rearrangements at the BRCA1 locus in Spanish families with breast/ovarian cancer Clin Chem 52 8 1480 1485 10.1373/clinchem.2006.070110
35. C Hartmann AL John R Klaes 2004 Large BRCA1 gene deletions are found in 3% of German high-risk breast cancer families Hum Mutat 24 6 534 10.1002/humu.9291
36. DJ Bunyan DM Eccles J Sillibourne 2004 Dosage analysis of cancer predisposition genes by multiplex ligation-dependent probe amplification Br J Cancer 91 6 1155 1159
37. I Belogianni A Apessos M Mihalatos 2004 Characterization of a novel large deletion and single point mutations in the BRCA1 gene in a Greek cohort of families with suspected hereditary breast cancer BMC Cancer 4 61
38. FB Hogervorst PM Nederlof JJ Gille 2003 Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method Cancer Res 63 7 1449 1453
39. T Wang I Lerer Z Guetan 2005 A Deletion/Insertion Mutation in the BRCA2 gene in a Breast Cancer Family: A Possiable Role of the Alu-polyA Tail in the Evolution of the Deletion Genes Chromosomes Cancer 31 91 95 10.1002/gcc.1110
40. PS Brzovic J Meza MC King 1998 The cancer-predisposing mutation C61G disrupts homodimer formation in the NH2-terminal BRCA1 RING finger domain J Biol Chem 273 14 7795 7799
41. SV Tavtigian AM Deffenbaugh L Yin 2006 Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral J Med Genet 43 295 305 10.1136/jmg.2005.033878
42. F Durocher D Shattuck-Eidens M McClure 1996 Comparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populations Hum Mol Genet 5 835 842 10.1093/hmg/5.6.835
43. DE Goldgar DF Easton AM Deffenbaugh 2004 Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2 Am J Hum Genet 75 535 544 10.1086/424388
44. T Judkins BC Hendrickson AM Deffenbaugh 2005 Application of embryonic lethal or other obvious phenotypes to characterize the clinical significance of genetic variants found in trans with known deleterious mutations Cancer Res 65 10096 10103 10.1158/0008-5472.CAN-05-1241